ClearMynd

ClearMynd is a specialized division of BioAdaptives, Inc. (OTC: BDPT) that develops and markets science-driven cognitive performance and brain health products. The division's flagship offering is the MyndSystem, a dual-phase cognitive support platform featuring MyndMed for daytime mental performance and MyndRenew for nighttime neurological recovery. These formulations utilize a precision-engineered blend of premium botanicals and nutraceuticals designed to optimize neurotransmitter systems, support neuroprotection, and enhance stress resilience. Historically, the name ClearMynd was also associated with ClearMynd Technology Solutions Corp., a Canadian entity focused on scalable synthetic chemistry for psilocybin and tryptamine compounds, which was acquired and amalgamated by Telescope Innovations Corp. in 2022.